Following the recent announcement of GlaxoSmithKline’s (GSK) withdrawal from the Nigerian pharmaceutical market, there has been a substantial surge in the prices of GSK medications, with reports indicating increases as high as 1000%. The abrupt rise in costs has triggered widespread concern among Nigerians, who have taken to social media to express their frustrations.
The soaring prices can be attributed to a combination of factors: GSK’s departure, a major player in the pharmaceutical industry, and the escalating rate of inflation in Nigeria. As of October 2023, the country’s inflation rate reached 27.33%, the highest recorded since August 2005. This persistent inflationary trend has significantly contributed to the rising costs of various goods and services, including pharmaceutical products.
The compounded impact of Nigeria’s escalating inflation and GSK’s exit from the local market has posed substantial challenges to the affordability and availability of medicines, creating hurdles for healthcare in the country.

**GSK’s Exit:**
On August 3, GlaxoSmithKline (GSK), a prominent UK-based pharmaceutical company, informed its Nigerian branch, GSK Consumer Nigeria Plc, about its decision to cease the direct commercialization of its prescription medicines and vaccines in Nigeria. The company opted for a third-party direct distribution model for its pharmaceutical products within the country, citing operational challenges, difficulty in maintaining a steady drug supply, and obstacles related to foreign exchange scarcity.
External factors such as regional insecurity, the removal of fuel subsidies by the government, and the overall high cost of doing business in Nigeria collectively influenced GSK’s strategic realignment in the Nigerian pharmaceutical market.
**Consequences on the Nigerian Pharmaceutical Market:**
Post GSK’s announcement, there has been a noticeable scarcity of GSK drugs across the country, affecting community pharmacies, particularly in Lagos. Nairametrics, now replaced with InfoStride News, has observed significant challenges faced by pharmacies in procuring various GSK medicines, attributing this difficulty primarily to the decreased availability of these drugs.
To illustrate the impact, a comparison of current prices (as of November 2023) with those before GSK’s exit has been compiled, focusing on commonly used GSK medications. This comparison highlights the disparities and provides a clear picture of how the market has been affected by the company’s strategic withdrawal.
**Reactions:**
InfoStride News conducted interviews with community pharmacists to delve into the causes of the recent surge in drug prices, customer reactions, and their expectations from the government. Pharmacists cited the major issue of foreign exchange rates and the departure of companies like GSK as key factors leading to price increases. Customers are now opting for cheaper brands, and the scarcity of medicines has resulted in increased demand and higher prices.
Addressing government intervention, pharmacists expressed the need for the government to work on the foreign exchange rate and make healthcare more accessible, especially in government hospitals, to ensure affordable drugs.
**Implications:**
According to the BMC Infectious Diseases Journal, there is a significant prevalence of antibiotic use in Nigerian hospitals, estimated at 78.2%, with GSK’s antibiotics among the most frequently prescribed due to their proven efficacy. The withdrawal of GSK implies increased medical expenses for those facing common bacterial infections.
In the context of respiratory illnesses, where asthma impacts between 14% to 18% of the general population in Nigeria, GSK’s role as the primary supplier of asthma medications has led to increased costs for asthma patients. This situation is exacerbated by current economic challenges and the scarcity of these crucial medications.
Support InfoStride News' Credible Journalism: Only credible journalism can guarantee a fair, accountable and transparent society, including democracy and government. It involves a lot of efforts and money. We need your support. Click here to Donate